| Target Price | $52.02 |
| Price | $32.88 |
| Potential |
58.21%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target PROCEPT BioRobotics 2026 .
The average PROCEPT BioRobotics target price is $52.02.
This is
58.21%
register free of charge
$78.75
139.51%
register free of charge
$39.39
19.80%
register free of charge
|
|
| A rating was issued by 19 analysts: 16 Analysts recommend PROCEPT BioRobotics to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the PROCEPT BioRobotics stock has an average upside potential 2026 of
58.21%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 224.50 | 332.93 |
| 64.84% | 48.30% | |
| EBITDA Margin | -40.70% | -12.01% |
| 47.39% | 70.49% | |
| Net Margin | -40.72% | -25.84% |
| 47.64% | 36.54% |
16 Analysts have issued a sales forecast PROCEPT BioRobotics 2025 . The average PROCEPT BioRobotics sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an PROCEPT BioRobotics EBITDA forecast 2025. The average PROCEPT BioRobotics EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
16 PROCEPT BioRobotics Analysts have issued a net profit forecast 2025. The average PROCEPT BioRobotics net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.75 | -1.54 |
| 21.88% | 12.00% | |
| P/E | negative | |
| EV/Sales | 4.79 |
16 Analysts have issued a PROCEPT BioRobotics forecast for earnings per share. The average PROCEPT BioRobotics EPS is
This results in the following potential growth metrics and future valuations:
PROCEPT BioRobotics...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Truist Securities |
Locked
➜
Locked
|
Locked | Dec 18 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Dec 12 2025 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Dec 08 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Dec 02 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Truist Securities:
Locked
➜
Locked
|
Dec 18 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Dec 12 2025 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Dec 08 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Dec 02 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Nov 05 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


